# Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3)

> **NCT07471958** · — · RECRUITING · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 360 (estimated)

## Conditions studied

- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07471958
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-02
- **Primary completion:** 2029-03
- **Final completion:** 2029-03
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2026-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07471958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07471958, "Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07471958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*